Sera Prognostics, Inc. (SERA)
2.05
-0.04
(-1.91%)
USD |
NASDAQ |
Oct 01, 16:00
2.05
0.00 (0.00%)
After-Hours: 19:55
Sera Prognostics Cash from Operations (Annual) : -25.62M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -25.62M |
| December 31, 2024 | -14.19M |
| December 31, 2023 | -27.19M |
| December 31, 2022 | -34.61M |
| Date | Value |
|---|---|
| December 31, 2021 | -31.64M |
| December 31, 2020 | -16.87M |
| December 31, 2019 | -19.32M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Myriad Genetics, Inc. | 1.80M |
| BioRestorative Therapies, Inc. | -10.79M |
| CareDx, Inc. | 42.03M |
| Natera, Inc. | 215.30M |
| Exagen, Inc. | -13.62M |